High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine
- PMID: 1491034
- DOI: 10.1016/0378-4347(92)80313-f
High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine
Abstract
A high-performance liquid chromatographic method is described which enables the determination of nicotinamide and eight of its possible metabolites in human and murine plasma and urine, using ion-pairing on a base-deactivated reversed-phase column. Calibration curves were linear up to 2 mumol/ml for nicotinamide and 200 nmol/ml for the metabolites; both the intra- and inter-assay relative standard deviations ranged between 1 and 8%. In murine plasma, the N-oxide was the major nicotinamide metabolite, but in man, formation of 1-methylnicotinamide and the 2- and 4-pyridones was also significant. In urine, nicotinuric acid was seen in the mouse, but no nicotinic acid metabolites were seen in man.
Similar articles
-
Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow.J Pharm Biomed Anal. 2001 Jan;24(3):391-404. doi: 10.1016/s0731-7085(00)00425-8. J Pharm Biomed Anal. 2001. PMID: 11199218
-
Simultaneous determination of nicotinic acid and its two metabolites in human plasma using solid-phase extraction in combination with high performance liquid chromatography.Int J Vitam Nutr Res. 1993;63(2):145-9. Int J Vitam Nutr Res. 1993. PMID: 8407165
-
Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry.J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 1;878(29):3033-8. doi: 10.1016/j.jchromb.2010.08.049. Epub 2010 Sep 9. J Chromatogr B Analyt Technol Biomed Life Sci. 2010. PMID: 20870468 Free PMC article.
-
High-performance liquid-chromatographic determination of free nicotinic acid and its metabolite, nicotinuric acid, in plasma and urine.Clin Chem. 1978 Oct;24(10):1740-3. Clin Chem. 1978. PMID: 699281
-
Determination of nicotinamide in human plasma and urine by ion-pair reversed-phase high-performance liquid chromatography.J Chromatogr. 1980 Nov 14;221(1):161-5. doi: 10.1016/s0378-4347(00)81019-1. J Chromatogr. 1980. PMID: 6450217 No abstract available.
Cited by
-
The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma.Mol Cell Biochem. 2004 Dec;267(1-2):25-30. doi: 10.1023/b:mcbi.0000049359.66669.29. Mol Cell Biochem. 2004. PMID: 15663182
-
Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoring.Br J Cancer. 1996 Jul;74(1):16-21. doi: 10.1038/bjc.1996.309. Br J Cancer. 1996. PMID: 8679452 Free PMC article.
-
Regulation of and challenges in targeting NAD+ metabolism.Nat Rev Mol Cell Biol. 2024 Oct;25(10):822-840. doi: 10.1038/s41580-024-00752-w. Epub 2024 Jul 18. Nat Rev Mol Cell Biol. 2024. PMID: 39026037 Review.
-
Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure.Pediatr Nephrol. 2006 Jun;21(6):800-6. doi: 10.1007/s00467-006-0072-z. Epub 2006 Apr 8. Pediatr Nephrol. 2006. PMID: 16604373
-
A method for comprehensive analysis of urinary acylglycines by using ultra-performance liquid chromatography quadrupole linear ion trap mass spectrometry.J Am Soc Mass Spectrom. 2010 Dec;21(12):2105-16. doi: 10.1016/j.jasms.2010.09.004. Epub 2010 Sep 18. J Am Soc Mass Spectrom. 2010. PMID: 20971021